Surveillance and control of asymptomatic carriers of drug-resistant bacteria

Drug-resistant bacterial infections constitute a major threat to global public health. Several key bacteria that are becoming increasingly resistant are among those that are ubiquitously carried by human beings and usually cause no symptoms (i.e. individuals are asymptomatic carriers) until and/or u...

Full description

Saved in:  
Bibliographic Details
Authors: Jamrozik, Euzebiusz (Author) ; Selgelid, Michael J. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Wiley-Blackwell [2019]
In: Bioethics
Year: 2019, Volume: 33, Issue: 7, Pages: 766-775
IxTheo Classification:NCH Medical ethics
Further subjects:B microbial determinism
B asymptomatic carrier
B Surveillance
B antimicrobial resistance
B Public Health Ethics
B drug resistance
Online Access: Volltext (Verlag)
Volltext (doi)

MARC

LEADER 00000caa a22000002 4500
001 1727504089
003 DE-627
005 20230426130552.0
007 cr uuu---uuuuu
008 200820s2019 xx |||||o 00| ||eng c
024 7 |a 10.1111/bioe.12642  |2 doi 
035 |a (DE-627)1727504089 
035 |a (DE-599)KXP1727504089 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Jamrozik, Euzebiusz  |e VerfasserIn  |4 aut 
245 1 0 |a Surveillance and control of asymptomatic carriers of drug-resistant bacteria 
264 1 |c [2019] 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Drug-resistant bacterial infections constitute a major threat to global public health. Several key bacteria that are becoming increasingly resistant are among those that are ubiquitously carried by human beings and usually cause no symptoms (i.e. individuals are asymptomatic carriers) until and/or unless a precipitating event leads to symptomatic infection (and thus disease). Carriers of drug-resistant bacteria can also transmit resistant pathogens to others, thus putting the latter at risk of resistant infections. Accumulating evidence suggests that such transmission occurs not only in hospital settings but also in the general community, although considerably more data are needed to assess the extent of this problem. Asymptomatic carriage of drug-resistant bacteria raises important ethical questions regarding the appropriate public health response, including the degree to which it would be justified to impose burdens on asymptomatic carriers (and others) in order to prevent transmission. In this paper, we (i) summarize current evidence regarding the carriage of key drug-resistant bacteria, noting important knowledge gaps; and (ii) explore the particular implications of existing public health ethics frameworks for policy-making regarding asymptomatic carriers. Inter alia, we argue that the relative burdens imposed by public health measures on healthy carriers (as opposed to sick individuals) warrant careful consideration and should be proportionate to the expected public health benefits in terms of risks averted. We conclude that more surveillance and research regarding community transmission will be needed in order to clarify relevant risks and design proportionate policies, although extensive community surveillance itself would also require careful ethical consideration. 
601 |a Controlling 
650 4 |a antimicrobial resistance 
650 4 |a asymptomatic carrier 
650 4 |a drug resistance 
650 4 |a microbial determinism 
650 4 |a Public Health Ethics 
650 4 |a Surveillance 
652 |a NCH 
700 1 |e VerfasserIn  |0 (DE-588)1063666287  |0 (DE-627)812435052  |0 (DE-576)422812129  |4 aut  |a Selgelid, Michael J. 
773 0 8 |i Enthalten in  |t Bioethics  |d Oxford [u.a.] : Wiley-Blackwell, 1987  |g 33(2019), 7, Seite 766-775  |h Online-Ressource  |w (DE-627)271596708  |w (DE-600)1480658-7  |w (DE-576)078707986  |x 1467-8519  |7 nnns 
773 1 8 |g volume:33  |g year:2019  |g number:7  |g pages:766-775 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12642  |x Verlag 
856 |u https://doi.org/10.1111/bioe.12642  |x doi  |3 Volltext 
936 u w |d 33  |j 2019  |e 7  |h 766-775 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 3741278300 
LOK |0 003 DE-627 
LOK |0 004 1727504089 
LOK |0 005 20210929173052 
LOK |0 008 200820||||||||||||||||ger||||||| 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo 
LOK |0 936ln  |0 1550736558  |a NCH 
ORI |a SA-MARC-ixtheoa001.raw